GLP-1 Receptor Agonist Clinical Evidence: Safety Guide
GLP-1 weight loss muscle loss clinical evidence highlights the importance of preserving lean muscle mass during therapy. Rapid weight loss with GLP-1 receptor agonists can lead to muscle loss if not managed properly. Adequate protein intake and…
Medical Cannabis vs Opioids: Insights from 3,500 Patient Survey Results
This article examines opioid substitution patterns cannabis based on a 3,500 patient survey. The findings provide real-world evidence on how patients use medical cannabis versus opioids. Understanding these patient-reported outcomes helps inform clinical…
GLP-1 Receptor Agonist Side Effects: New Clinical Evidence
GLP-1 receptor agonist side effects are increasingly recognized through patient-reported outcomes and real-world evidence. This new clinical evidence highlights symptoms beyond traditional trial data. Understanding these side effects helps clinicians…
Putting Patients First in Drug Development | Applied Clinical Trials Online
Patient-centered drug development is transforming cannabis research by prioritizing patient experiences and real-world evidence. This approach captures complex dosing and symptom relief patterns often missed by traditional trials. Patient-centered drug…
Discrepancies between subjective and objective cognition in persons with multiple sclerosis: Exploring the role of cannabis use.
This study investigates cannabis cognitive effects multiple sclerosis patients experience, revealing discrepancies between subjective complaints and objective testing. Cannabis users with MS report greater perceived cognitive deficits than non-users.…
Exploring Patient Views on Off-Label Cannabidiol Use for Insomnia
This study examines patient perceptions of off-label cannabidiol use for insomnia through sentiment analysis. It offers insights into real-world experiences beyond clinical trials. Understanding these perceptions helps inform cautious clinical guidance…
12-Month Patient-Reported Outcomes After Elective Spine Surgery with Substance Screening
This study highlights the importance of preoperative substance screening spine surgery outcomes over a 12-month period. Patient-reported outcomes provide valuable insights into recovery trajectories among substance users. The focus on urine toxicology…
Health-related quality of life in patients receiving medicinal cannabis: systematic review and meta-analysis of primary research findings 2015-2025.
This systematic review and meta-analysis examines health-related quality of life medicinal cannabis outcomes in patients with chronic conditions. The study standardizes outcome measurement across multiple timeframes. Findings support improved quality of…